Fluorescence molecular imaging of high-grade gliomas and brain metastases using the RAS70 peptide targeting plasma membrane-bound Hsp70 on tumor cells.

Saved in:
Bibliographic Details
Title: Fluorescence molecular imaging of high-grade gliomas and brain metastases using the RAS70 peptide targeting plasma membrane-bound Hsp70 on tumor cells.
Authors: Nechaeva A; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, Mayakovskogo Str. 12, St. Petersburg, 191014, Russia.; Personalized Medicine Centre, Almazov National Medical Research Centre, Akkuratova Str. 2, St. Petersburg, 197341, Russia., Ulitin A; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, Mayakovskogo Str. 12, St. Petersburg, 191014, Russia., Sitovskaya D; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, Mayakovskogo Str. 12, St. Petersburg, 191014, Russia., Yudintceva N; Personalized Medicine Centre, Almazov National Medical Research Centre, Akkuratova Str. 2, St. Petersburg, 197341, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave. 4, St. Petersburg, 194064, Russia., Bobkov D; Personalized Medicine Centre, Almazov National Medical Research Centre, Akkuratova Str. 2, St. Petersburg, 197341, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave. 4, St. Petersburg, 194064, Russia., Likhomanova R; Personalized Medicine Centre, Almazov National Medical Research Centre, Akkuratova Str. 2, St. Petersburg, 197341, Russia.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave. 4, St. Petersburg, 194064, Russia., Olyushin V; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, Mayakovskogo Str. 12, St. Petersburg, 191014, Russia., Kim A; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, Mayakovskogo Str. 12, St. Petersburg, 191014, Russia., Samochernykh K; Polenov Neurosurgical Institute, Almazov National Medical Research Centre, Mayakovskogo Str. 12, St. Petersburg, 191014, Russia.; Personalized Medicine Centre, Almazov National Medical Research Centre, Akkuratova Str. 2, St. Petersburg, 197341, Russia., Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany., Shevtsov M; Personalized Medicine Centre, Almazov National Medical Research Centre, Akkuratova Str. 2, St. Petersburg, 197341, Russia. maxim.shevtsov@tum.de.; Laboratory of Biomedical Nanotechnologies, Institute of Cytology of the Russian Academy of Sciences (RAS), Tikhoretsky Ave. 4, St. Petersburg, 194064, Russia. maxim.shevtsov@tum.de.; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich, Ismaninger Str. 22, 81675, Munich, Germany. maxim.shevtsov@tum.de.
Source: Journal of neuro-oncology [J Neurooncol] 2025 Oct 15; Vol. 176 (1), pp. 15. Date of Electronic Publication: 2025 Oct 15.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1573-7373
DOI:10.1007/s11060-025-05245-0